What is HGH 191AA?
The mg-based example below comes from a published educational reference for a different 10 IU vial. Peak currently lists two research-only HGH 191 kits: 120 IU total (10 vials × 12 IU) and 320 IU total (10 vials × 32 IU). The photographed kits are not the reference vial or an approved somatropin medicine.
Research classification: IU-labelled research kits · 12 or 32 IU per vial; no validated human kit regimen. The HGH 191AA 12 IU/vial · 120 IU kit kit label reports nominal content; it does not state a suitable amount for human use.
Mechanism and research questions
Growth-hormone receptor signalling can affect IGF-1 expression and metabolism in studied contexts. This does not validate Peak research kits for treatment or performance use.
Mechanistic findings and early experiments do not by themselves establish clinical efficacy, an approved treatment cycle or equivalence between suppliers' formulations. Interpret claims in the context of the specific experimental model and references.
How to read a reported schedule
The earlier 10 IU-vial educational example lists amounts from 0.2 mg to 0.9 mg across weeks 1–8. Its diluent volume and syringe-unit values describe that different vial, not Peak's pictured 12 IU and 32 IU research vials. The sourced HGH IU-to-mg guide explains why 10 IU is approximately 3.33 mg only where the product documents 3 IU/mg. The Australian Genotropin product information contains separate, clinician-directed mg dosing for its licensed formulation; it does not validate the old fixed-week sequence or either research kit.
For the existing schedule, its evidence caveats and the distinct IU kit labels, see the HGH 191AA protocol and kit reference. Figures displayed there are research context, not a personalised prescription.
Vial identity and preparation
An exact-matching Peak Peptides Australia 12 IU/vial · 120 IU kit kit is shown on the research reference page. The product is supplied for in-vitro research, not administration.
Reconstitution cannot be inferred from vial strength alone. Confirm the exact compound, lot, expected appearance, compatible sterile diluent, final volume, transfer method and discard/storage period from validated formulation documentation. BAC water and a 28-day period are not universal defaults. See the illustrated product-specific preparation guide and the abnormal-solution safety guide.
View Peak Peptides Australia's research-only listing and confirm its current labelled strength.
Sources, limits and next steps
- Earlier HGH 10 IU-vial educational example — original mg sequence; different vial
- Australian Genotropin product information — licensed somatropin mg dosing only
- Peak Peptides Australia HGH kit listings — 120 IU and 320 IU shop cards
For clinical decisions, consult a qualified professional and the product information for an approved formulation. Research-only supplier material must not be injected or used to treat a condition. Explore the A–Z research directory to compare evidence categories.